Wilson Sonsini Goodrich & Rosati advised Ripple on the transaction. Ripple Therapeutics Corporation (Ripple) announced a collaboration and option-to-license agreement with AbbVie to develop RTC-620, a...
Ripple Therapeutics’ License Agreement with AbbVie
Genstar Capital’s Majority Investment in Flourish Research
Ropes & Gray represented Genstar Capital in the transaction, and McDermott Will & Emery represented Flourish Research. Flourish Research (“Flourish” or the “Company”) announced a strategic...
SCF Partners’ Acquisition of Newpark’s Fluids Systems Segment
Vinson and Elkins advised SCF Partners, Inc. on the transaction, and Baker McKenzie advised Newpark Resources, Inc. Newpark Resources, Inc. (NYSE: NR) (“Newpark” or the “Company”)...
Apollo Funds’ Acquisition of Freedom CNG
Baker Botts and Crady Jewett McCulley & Houren advised Freedom Fuel, LLC, an owner of Freedom CNG on the deal, while Vinson & Elkins advised Apollo...
RunSafe’s $12 Million Series B Funding Round
Wilmer Cutler Pickering Hale and Dorr represented RunSafe Security in the transaction. RunSafe Security, the pioneer of a patented process to immunize software from cyberattacks without...
Vistra’s Acquisition of Equity Interests of Vistra Vision LLC
Sidley Austin and Latham & Watkins are representing Vistra Corp. in the transaction, while Kramer Levin Naftalis & Frankel is representing Nuveen Asset Management, LLC and...
Publicis Groupe’s Acquisition of Mars United Commerce
Gibson, Dunn & Crutcher is advising Publicis Groupe on the transaction. Publicis Groupe [Euronext Paris FR0000130577, CAC 40] announced the acquisition of Mars United Commerce, the...
Focus Financial’s $4.3 Billion Refinancing
Debevoise & Plimpton has advised Focus Financial Partners in the deal. Focus Financial Partners announced the $4.276 billion refinancing of Focus’s existing debt facilities. The refinancing...
TeamBridge’s $28 Million Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Mayfield in the transaction. TeamBridge, the fastest-growing Workforce OS (workforce operating system) empowering hourly workforces, has raised $28...
Zenas BioPharma’s $225 Million IPO
Ropes & Gray represented Zenas BioPharma in the transaction, and Cooley represented the underwriters. Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company, announced...
Switch Bioworks’ $17 Million Series Seed Financing
Fenwick & West represented Switch Bioworks in the transaction. Switch Bioworks, a biotechnology company, announced raising $17 million in series seed financing. The round was led...
Circle Pharma’s $90 Million Series D Financing Round
Wilson Sonsini Goodrich & Rosati represented Circle Pharma in the transaction. Circle Pharma, a clinical-stage biopharmaceutical company, announced the closing of a $90 million Series D...